Michael E. Coyle

Hematology
295 Varnum Ave
Lowell, MA 01854

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Journal: American journal of hematology
Published: September 10, 2024

The evolving role of response-adapted PET imaging in Hodgkin lymphoma.

The evolving role of response-adapted PET imaging in Hodgkin lymphoma.

Journal: Therapeutic advances in hematology
Published: April 08, 2016

Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Journal: Cancer research
Published: September 04, 2015

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities.

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities.

Journal: Blood
Published: November 12, 2014
Showing 1-4 of 4

Last Updated: 09/26/2026